Karyopharm Therapeutics, Inc. (KPTI)
7.31
-0.03
(-0.41%)
USD |
NASDAQ |
Dec 30, 16:00
7.301
-0.01
(-0.12%)
After-Hours: 20:00
Karyopharm Therapeutics Market Cap: 124.64M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bruker Corp. | 7.219B |
| TG Therapeutics, Inc. | 4.723B |
| Actinium Pharmaceuticals, Inc. | 43.99M |
| Axsome Therapeutics, Inc. | 7.501B |
| Krystal Biotech, Inc. | 7.188B |
Market Cap Related Metrics
| PS Ratio | 0.4379 |
| PEG Ratio | -0.0004 |
| Price | 7.31 |
| Earnings Yield | -199.5% |
| PEGY Ratio | -0.0004 |